Ovarian Cancer Clinical Trials

Showing 541-560 of 574 trials

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

NCT00900406

RATIONALE: Collecting and storing samples of blood, urine, and tissue from patients undergoing a donor stem cell transplant to test in the laboratory may help the study of graft-versus-host disease in the future. PURPOSE: This research study is collecting and storing tissue and DNA samples from patients undergoing a donor stem cell transplant.

Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more

Vanderbilt-Ingram Cancer Center190 participantsStarted Jan 2007

Nashville, Tennessee, United States • Nashville, Tennessee, United States • Nashville, Tennessee, United States

TERMINATED

Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer

NCT00288275

Chemoresponse assays (lab test) measure the effect that chemotherapy treatment has on a patient's cancer cells in the lab. This test has shown success in a retrospective study in predicting how an individual patient's tumor will respond to a given chemotherapy and how treatment utilizing an agent that the test said that a patient's cells would be sensitive too corresponds to a longer progression free interval. This study will determine the ability of two tests used to predict the success of chemotherapy in recurrent, persistent, or refractory cancer of the ovaries, fallopian tube(s) or peritoneum by measuring how long patients live without progression.

Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms

Precision Therapeutics256 participantsStarted Jul 2004

Irvine, California, United States • Los Angeles, California, United States • New Haven, Connecticut, United States +33 more locations

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer

Related Searches

Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer

Quality-of-Life Assessment in Patients With Ovarian Cancer

Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer

PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer

ICON8: Weekly Chemotherapy in Ovarian Cancer

Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer

Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer

Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Epidemiology of Ovarian Cancer in Taiwan

Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors

Clinical Benefit of Topoisomerase Downregulation

Bone Health in Gynecologic Cancers-does FOSAVANCE Help?

Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas

Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis